Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 1,031–1,040 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 1031

    Medicine slug
    moexipril
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    3
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 13%

      Numeric value
      13
      Unit
      %
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d4078f3-b621-475f-a4e6-005de2e62b32 (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        Bioavailability of oral moexipril is about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces the peak plasma level (C max ) and AUC (see Absorption).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:baac91ad-f8ee-4694-89f8-5c47a8eda39a (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        Bioavailability of oral moexipril is about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces the peak plasma level (C max ) and AUC (see Absorption).

  2. Projected row 1032

    Medicine slug
    moexipril
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    3
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 2 to 9 hours

      Numeric value
      2
      Unit
      hours
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d4078f3-b621-475f-a4e6-005de2e62b32 (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        The time of peak plasma concentration (T max ) of moexiprilat is about 1½ hours and elimination half-life (t 1/2 ) is estimated at 2 to 9 hours in various studies, the variability reflecting a complex elimination pattern that is not simply exponential.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:baac91ad-f8ee-4694-89f8-5c47a8eda39a (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        The time of peak plasma concentration (T max ) of moexiprilat is about 1 1/2 hours and elimination half-life (t 1/2 ) is estimated at 2 to 9 hours in various studies, the variability reflecting a complex elimination pattern that is not simply exponential.

  3. Projected row 1033

    Medicine slug
    moexipril
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    3
    Source count
    2
    Agreement rate
    1
    Recorded readings

    1. 183 liters

      Numeric value
      183
      Unit
      L
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d4078f3-b621-475f-a4e6-005de2e62b32 (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        The volume of distribution of moexiprilat is about 183 liters.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:baac91ad-f8ee-4694-89f8-5c47a8eda39a (opens source in a new tab)

        Moexipril label

        Version not recorded · Effective date not recorded

        The volume of distribution of moexiprilat is about 183 liters.

  4. Projected row 1034

    Medicine slug
    montelukast
    Compared field
    bioavailability
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    68
    Source count
    67
    Agreement rate
    0.985075
    Recorded readings

    1. 64%

      Numeric value
      64
      Unit
      %
      Source records
      66

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 66 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c69ab399-8ea6-4002-9271-b6a57c862b14 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0c5b856-3f70-4ca6-9763-a90673bb82fb (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fe3c0d4-94ff-43ca-9d24-54676fe593fe (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ba27278-6249-4546-9331-b19302cbf2db (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0daaaf3-6717-4a01-e053-2995a90af2d8 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9beb1510-f3af-4269-a9d0-e2bd41ac369b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a682c2-7e00-4d07-a5ac-4436c977f842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9287d2f1-2414-4ee2-aecc-b6b59c6a0a4c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ffff72c-8784-477b-8722-5434a19881a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7870c45-5a8b-8369-e053-2a95a90ae1f3 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:23964723-2df8-4d0a-a53d-8538469672f1 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461f2aaa-e091-478e-97c1-27a089db8cdc (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f2dbf17-bce0-4e09-8c22-898d93be80da (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb1b2e4e-a840-447b-b943-ad0b6acc32b5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a7c11cbe-0834-27a5-e053-2995a90ac43f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce512844-5220-4661-809f-56d088699c9c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da038cf6-cfad-43a4-ab8e-d81d028d6087 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fbdf1be-a37f-879b-e063-6394a90aa20d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:901385e5-7384-4c28-a36a-7dd84c36f5fd (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75723c5a-3c9e-468a-bc65-57b4c755889a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba42b0a9-83f1-4283-a853-f99cdd0761b9 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbbf0d6-efd9-4fdd-9e7b-e3d293062609 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da9821f1-536a-416b-9594-210bde0cefaf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94642db1-5c75-44c4-92b4-8385b486df82 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a312a28-8472-4cab-a7dd-d01cd8b2765a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:482dcc92-b47f-4ea6-854a-f5ac2aea7842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:583a9499-97f0-2ebf-e063-6394a90a35af (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a3bfc59-0ca6-4433-abf5-41659bfe0a8f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ce48faf-4504-488a-8b20-3e8d4f008fb2 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4dc63cf-8145-42f4-9437-93b414d2aed4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c43d1edb-c162-4317-9a89-d84e4eff5512 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6eea668f-a2fa-447f-b2d5-4c754d13d9fa (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a724790-e1fb-4935-bb28-ce99455be5ef (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83c35a3d-0bbc-4598-bf76-ab0c2903bf19 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:56429f04-97b6-06a9-e054-00144ff88e88 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed2caffa-a75c-1c27-ae30-2d8280eaea7d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:25b2049d-3a93-4ac3-8de6-14f5d7ce0315 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b26218d-52a6-4109-90e4-412a17d14fcf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e375c07-70db-458c-9336-22a7037b0a5f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04b3faff-1ea1-4d2a-aa31-9d6e742e1759 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:365e1c5c-01b2-bf4e-e063-6394a90a0e43 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82d65eea-c7c9-4e16-9176-46c43f00f0f6 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6741830f-5d90-4066-bc3b-065059bc150d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d5fbea-b183-41c9-a20f-30da1f44ab1b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ff4100f-11e3-4d6a-ab88-83bd605a1818 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecaa9b4b-5941-4af5-930c-35e9f3b2b4ba (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1eeb3123-9e93-4681-8096-800a7c7acf8a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cab84c43-96a3-4868-88da-3126685edf00 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9705627c-283e-4743-b261-cfeb88d96e9b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3bdf2a3-d661-5128-e053-2995a90a4661 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4451a9-d73d-b9de-68ec-853bfeff6e4b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f90a573-27fd-cc16-f3d1-8c4d630224a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d69e73a-76cb-4ece-9cf9-e9adb4f523b4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67070e4e-f755-46b3-b900-fcc1993a0546 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49669ac0-0bb5-4576-bed5-9e85e0d76a44 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64a3b181-e8d8-4caf-9f1b-e0063d0bd94a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09b0bc9e-3035-45b4-b61b-4aca70848360 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9ec1996-6a54-4622-b8a6-57dea49f6b35 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c411d3e-47b6-481b-b846-419ed4cbb947 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97cc4e1e-e0fd-4bb5-8f9e-b8573f5230e5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54014b67-3163-4c8f-b93a-229cd231ca6b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:549f1d1a-81f5-29f5-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:566a8fd7-fc00-2297-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7ff11e37-9ea5-40b6-96f7-4caf27cab756 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5cb4298c-10b1-4d6f-95ad-4aad72daf249 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 64%.

    2. 73%

      Numeric value
      73
      Unit
      %
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bcd49102-a21c-4628-a322-6cdd934e7f09 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The mean oral bioavailability is 73% in the fasted state versus 63% when administered with a standard meal in the morning.

  5. Projected row 1035

    Medicine slug
    montelukast
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    68
    Source count
    67
    Agreement rate
    0.985075
    Recorded readings

    1. 2.7 to 5.5 hours

      Numeric value
      2.7
      Unit
      hours
      Source records
      66

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 66 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c69ab399-8ea6-4002-9271-b6a57c862b14 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0c5b856-3f70-4ca6-9763-a90673bb82fb (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fe3c0d4-94ff-43ca-9d24-54676fe593fe (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ba27278-6249-4546-9331-b19302cbf2db (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0daaaf3-6717-4a01-e053-2995a90af2d8 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9beb1510-f3af-4269-a9d0-e2bd41ac369b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a682c2-7e00-4d07-a5ac-4436c977f842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9287d2f1-2414-4ee2-aecc-b6b59c6a0a4c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ffff72c-8784-477b-8722-5434a19881a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7870c45-5a8b-8369-e053-2a95a90ae1f3 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:23964723-2df8-4d0a-a53d-8538469672f1 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461f2aaa-e091-478e-97c1-27a089db8cdc (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f2dbf17-bce0-4e09-8c22-898d93be80da (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb1b2e4e-a840-447b-b943-ad0b6acc32b5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a7c11cbe-0834-27a5-e053-2995a90ac43f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bcd49102-a21c-4628-a322-6cdd934e7f09 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce512844-5220-4661-809f-56d088699c9c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da038cf6-cfad-43a4-ab8e-d81d028d6087 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fbdf1be-a37f-879b-e063-6394a90aa20d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:901385e5-7384-4c28-a36a-7dd84c36f5fd (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75723c5a-3c9e-468a-bc65-57b4c755889a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba42b0a9-83f1-4283-a853-f99cdd0761b9 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbbf0d6-efd9-4fdd-9e7b-e3d293062609 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da9821f1-536a-416b-9594-210bde0cefaf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94642db1-5c75-44c4-92b4-8385b486df82 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a312a28-8472-4cab-a7dd-d01cd8b2765a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:482dcc92-b47f-4ea6-854a-f5ac2aea7842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:583a9499-97f0-2ebf-e063-6394a90a35af (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a3bfc59-0ca6-4433-abf5-41659bfe0a8f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ce48faf-4504-488a-8b20-3e8d4f008fb2 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4dc63cf-8145-42f4-9437-93b414d2aed4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c43d1edb-c162-4317-9a89-d84e4eff5512 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6eea668f-a2fa-447f-b2d5-4c754d13d9fa (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a724790-e1fb-4935-bb28-ce99455be5ef (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83c35a3d-0bbc-4598-bf76-ab0c2903bf19 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:56429f04-97b6-06a9-e054-00144ff88e88 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed2caffa-a75c-1c27-ae30-2d8280eaea7d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:25b2049d-3a93-4ac3-8de6-14f5d7ce0315 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b26218d-52a6-4109-90e4-412a17d14fcf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e375c07-70db-458c-9336-22a7037b0a5f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04b3faff-1ea1-4d2a-aa31-9d6e742e1759 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:365e1c5c-01b2-bf4e-e063-6394a90a0e43 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82d65eea-c7c9-4e16-9176-46c43f00f0f6 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6741830f-5d90-4066-bc3b-065059bc150d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d5fbea-b183-41c9-a20f-30da1f44ab1b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ff4100f-11e3-4d6a-ab88-83bd605a1818 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecaa9b4b-5941-4af5-930c-35e9f3b2b4ba (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1eeb3123-9e93-4681-8096-800a7c7acf8a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cab84c43-96a3-4868-88da-3126685edf00 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9705627c-283e-4743-b261-cfeb88d96e9b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3bdf2a3-d661-5128-e053-2995a90a4661 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f90a573-27fd-cc16-f3d1-8c4d630224a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d69e73a-76cb-4ece-9cf9-e9adb4f523b4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67070e4e-f755-46b3-b900-fcc1993a0546 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49669ac0-0bb5-4576-bed5-9e85e0d76a44 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64a3b181-e8d8-4caf-9f1b-e0063d0bd94a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09b0bc9e-3035-45b4-b61b-4aca70848360 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9ec1996-6a54-4622-b8a6-57dea49f6b35 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c411d3e-47b6-481b-b846-419ed4cbb947 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97cc4e1e-e0fd-4bb5-8f9e-b8573f5230e5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54014b67-3163-4c8f-b93a-229cd231ca6b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:549f1d1a-81f5-29f5-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:566a8fd7-fc00-2297-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7ff11e37-9ea5-40b6-96f7-4caf27cab756 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5cb4298c-10b1-4d6f-95ad-4aad72daf249 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        In several studies, the mean plasma half-life of montelukast ranged from 2.7 to 5.5 hours in healthy young adults.

    2. 7.4 hours

      Numeric value
      7.4
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4451a9-d73d-b9de-68ec-853bfeff6e4b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The elimination of montelukast was slightly prolonged compared with that in healthy subjects (mean half-life, 7.4 hours).

  6. Projected row 1036

    Medicine slug
    montelukast
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    68
    Source count
    67
    Agreement rate
    1
    Recorded readings

    1. 8 to 11 liters

      Numeric value
      8
      Unit
      L
      Source records
      67

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 67 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c69ab399-8ea6-4002-9271-b6a57c862b14 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0c5b856-3f70-4ca6-9763-a90673bb82fb (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fe3c0d4-94ff-43ca-9d24-54676fe593fe (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ba27278-6249-4546-9331-b19302cbf2db (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0daaaf3-6717-4a01-e053-2995a90af2d8 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9beb1510-f3af-4269-a9d0-e2bd41ac369b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97a682c2-7e00-4d07-a5ac-4436c977f842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9287d2f1-2414-4ee2-aecc-b6b59c6a0a4c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ffff72c-8784-477b-8722-5434a19881a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d7870c45-5a8b-8369-e053-2a95a90ae1f3 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:23964723-2df8-4d0a-a53d-8538469672f1 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461f2aaa-e091-478e-97c1-27a089db8cdc (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f2dbf17-bce0-4e09-8c22-898d93be80da (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb1b2e4e-a840-447b-b943-ad0b6acc32b5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a7c11cbe-0834-27a5-e053-2995a90ac43f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bcd49102-a21c-4628-a322-6cdd934e7f09 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady-state volume of distribution of montelukast averages 8 to 11 liters.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ce512844-5220-4661-809f-56d088699c9c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da038cf6-cfad-43a4-ab8e-d81d028d6087 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fbdf1be-a37f-879b-e063-6394a90aa20d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:901385e5-7384-4c28-a36a-7dd84c36f5fd (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75723c5a-3c9e-468a-bc65-57b4c755889a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba42b0a9-83f1-4283-a853-f99cdd0761b9 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbbf0d6-efd9-4fdd-9e7b-e3d293062609 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady-state volume of distribution of montelukast averages 8 to 11 liters.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da9821f1-536a-416b-9594-210bde0cefaf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94642db1-5c75-44c4-92b4-8385b486df82 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a312a28-8472-4cab-a7dd-d01cd8b2765a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:482dcc92-b47f-4ea6-854a-f5ac2aea7842 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:583a9499-97f0-2ebf-e063-6394a90a35af (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a3bfc59-0ca6-4433-abf5-41659bfe0a8f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ce48faf-4504-488a-8b20-3e8d4f008fb2 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4dc63cf-8145-42f4-9437-93b414d2aed4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c43d1edb-c162-4317-9a89-d84e4eff5512 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6eea668f-a2fa-447f-b2d5-4c754d13d9fa (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a724790-e1fb-4935-bb28-ce99455be5ef (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83c35a3d-0bbc-4598-bf76-ab0c2903bf19 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:56429f04-97b6-06a9-e054-00144ff88e88 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed2caffa-a75c-1c27-ae30-2d8280eaea7d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:25b2049d-3a93-4ac3-8de6-14f5d7ce0315 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b26218d-52a6-4109-90e4-412a17d14fcf (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e375c07-70db-458c-9336-22a7037b0a5f (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04b3faff-1ea1-4d2a-aa31-9d6e742e1759 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:365e1c5c-01b2-bf4e-e063-6394a90a0e43 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82d65eea-c7c9-4e16-9176-46c43f00f0f6 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6741830f-5d90-4066-bc3b-065059bc150d (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07d5fbea-b183-41c9-a20f-30da1f44ab1b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ff4100f-11e3-4d6a-ab88-83bd605a1818 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecaa9b4b-5941-4af5-930c-35e9f3b2b4ba (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1eeb3123-9e93-4681-8096-800a7c7acf8a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cab84c43-96a3-4868-88da-3126685edf00 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9705627c-283e-4743-b261-cfeb88d96e9b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3bdf2a3-d661-5128-e053-2995a90a4661 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4451a9-d73d-b9de-68ec-853bfeff6e4b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f90a573-27fd-cc16-f3d1-8c4d630224a0 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d69e73a-76cb-4ece-9cf9-e9adb4f523b4 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67070e4e-f755-46b3-b900-fcc1993a0546 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49669ac0-0bb5-4576-bed5-9e85e0d76a44 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64a3b181-e8d8-4caf-9f1b-e0063d0bd94a (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09b0bc9e-3035-45b4-b61b-4aca70848360 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9ec1996-6a54-4622-b8a6-57dea49f6b35 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4c411d3e-47b6-481b-b846-419ed4cbb947 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97cc4e1e-e0fd-4bb5-8f9e-b8573f5230e5 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54014b67-3163-4c8f-b93a-229cd231ca6b (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:549f1d1a-81f5-29f5-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:566a8fd7-fc00-2297-e054-00144ff8d46c (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7ff11e37-9ea5-40b6-96f7-4caf27cab756 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5cb4298c-10b1-4d6f-95ad-4aad72daf249 (opens source in a new tab)

        Montelukast label

        Version not recorded · Effective date not recorded

        The steady state volume of distribution of montelukast averages 8 to 11 liters.

  7. Projected row 1037

    Medicine slug
    morphine
    Compared field
    bioavailability
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    75
    Source count
    58
    Agreement rate
    0.586207
    Recorded readings

    1. 40%

      Numeric value
      40
      Unit
      %
      Source records
      34

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 34 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2da87bfa-11fd-43e3-8fef-d16ebeb15680 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4f9a7cd-fa6c-41cd-8c4b-04626cfa410a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:efccad6e-213b-4335-9a4f-3b81322f77c4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:300b6afd-bac8-32ca-e063-6294a90a12a7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ceb3205-2f8d-4ba3-9f27-dc328bab4fa1 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b7b86b6d-9a39-494c-bf65-f62e4cdc5807 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae57637e-a86a-4ea5-9c68-47d98153d41a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:996ac31e-589f-4d5a-84bc-8350e7ea864f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d800d8e-8fe2-453b-a8ac-dcf7c47e55fc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6654b91e-3b3f-4062-ac65-a2a70f942da4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5422cdac-8073-41fc-8665-ffe9797f5c02 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e9a7319a-bf1f-48db-a71e-6d4e6ead9555 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:905cd842-2c86-4318-a6c4-92f49de145b3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d66d0cfb-9bfe-490c-90ee-49481c567e85 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca359246-4674-4b32-b8b2-673d32b7112f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8598654-94ad-4cfb-81d2-9b68e013a428 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b69f67f-30b3-4982-953e-5a4b87ec6ac6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58476a6b-b54b-5491-e063-6394a90a38c6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72e2071a-43d6-4480-bb84-4984a976618b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:367d508b-3226-42a9-8dc6-f67cdc9979f3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c847554-3b4b-4d24-a145-2ef7e9b83699 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9405556c-20e0-4e47-b1b0-7872bcc6517e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57ee014e-744e-65e1-e063-6394a90a8c93 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb6b3439-9f0c-45f5-bf6f-c7a971af0a8f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e32b869-31c7-48c1-98ae-b21bd28151d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9bb1fef7-4159-4dca-8a8c-37e53ccc6bab (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f1ba2a2-d8ac-4f59-a587-fe413e56dcdb (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b0b4ac-69d9-44bf-b7a3-229bd89b9fd6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:242c2512-1d49-486b-a9c3-6905f667799e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:649d731b-962a-45df-b043-7e0781e8a530 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67f0ee8d-696e-4c08-9007-3df0e3988bad (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76966c05-df75-4072-ae99-97e42f91ab75 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07593aa4-f2c4-4d6e-b186-ab2a4ecaa38a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66a3f607-7f48-490f-84dd-b74dd1ee39e5 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine sulfate is less than 40% and shows large inter-individual variability due to extensive pre-systemic metabolism.

    2. 20 to 40%

      Numeric value
      20
      Unit
      %
      Source records
      24

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 24 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad08cd86-3825-4e77-bbe8-f6333a9ca9d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f15f27b-95ed-4cc8-8937-eae07917a6dd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a89d0ca-4ff8-4bdc-8ea8-9ad591ce7226 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20af0f0e-45cc-4795-97ef-90b659575b34 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:533034fd-c8e7-495b-8874-0db41bd1e65a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dbb37dfd-0196-45f7-b9ca-393f56cf1d28 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:872ceecb-1f14-7a43-7451-e4650a01fbd9 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73a39ce5-b2ab-47b9-8860-796f1d5bc8d8 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c94d9da6-7a12-44ee-a38f-3323ee27842c (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c354b3bf-86c0-4bb8-8b1f-be2164942698 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a1ca529-8268-4be3-b03f-b2f2238cc9dc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7f65fa22-c3fc-4413-8a07-2c6be621b7bf (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f915420d-981d-455b-b4cf-67c8e201a136 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07993f6c-146b-4728-a2da-6e93089f78ff (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:736c9b80-682c-4cda-bf18-61b18de0bd39 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb9f929b-8c5a-442b-9695-9d3d45272a5e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd98b881-5466-457b-b5af-f102aec61546 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:47ea2424-ce2f-4b3b-b393-da1886e7a383 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc3b491c-a206-3027-54f0-f87c0dd40a7f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2dd52157-3121-41ed-abc2-99b269531e56 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19c7d9cc-6ce2-4c5c-8c3f-c24fd3342804 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e310662-16e8-4179-883e-efbca736b14d (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d360a33f-6323-4b10-9e81-07e2813c2dbd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:595243fe-a4b1-479a-99d6-a084a4181891 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The oral bioavailability of morphine is approximately 20 to 40%.

  8. Projected row 1038

    Medicine slug
    morphine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    75
    Source count
    71
    Agreement rate
    0.464789
    Recorded readings

    1. 15 hours

      Numeric value
      15
      Unit
      hours
      Source records
      33

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 33 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4f9a7cd-fa6c-41cd-8c4b-04626cfa410a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:efccad6e-213b-4335-9a4f-3b81322f77c4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:300b6afd-bac8-32ca-e063-6294a90a12a7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ceb3205-2f8d-4ba3-9f27-dc328bab4fa1 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b7b86b6d-9a39-494c-bf65-f62e4cdc5807 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae57637e-a86a-4ea5-9c68-47d98153d41a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:996ac31e-589f-4d5a-84bc-8350e7ea864f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d800d8e-8fe2-453b-a8ac-dcf7c47e55fc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6654b91e-3b3f-4062-ac65-a2a70f942da4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5422cdac-8073-41fc-8665-ffe9797f5c02 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e9a7319a-bf1f-48db-a71e-6d4e6ead9555 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:905cd842-2c86-4318-a6c4-92f49de145b3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d66d0cfb-9bfe-490c-90ee-49481c567e85 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca359246-4674-4b32-b8b2-673d32b7112f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8598654-94ad-4cfb-81d2-9b68e013a428 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b69f67f-30b3-4982-953e-5a4b87ec6ac6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58476a6b-b54b-5491-e063-6394a90a38c6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72e2071a-43d6-4480-bb84-4984a976618b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:367d508b-3226-42a9-8dc6-f67cdc9979f3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c847554-3b4b-4d24-a145-2ef7e9b83699 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9405556c-20e0-4e47-b1b0-7872bcc6517e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57ee014e-744e-65e1-e063-6394a90a8c93 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb6b3439-9f0c-45f5-bf6f-c7a971af0a8f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e32b869-31c7-48c1-98ae-b21bd28151d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9bb1fef7-4159-4dca-8a8c-37e53ccc6bab (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f1ba2a2-d8ac-4f59-a587-fe413e56dcdb (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b0b4ac-69d9-44bf-b7a3-229bd89b9fd6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:242c2512-1d49-486b-a9c3-6905f667799e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:649d731b-962a-45df-b043-7e0781e8a530 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67f0ee8d-696e-4c08-9007-3df0e3988bad (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76966c05-df75-4072-ae99-97e42f91ab75 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07593aa4-f2c4-4d6e-b186-ab2a4ecaa38a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66a3f607-7f48-490f-84dd-b74dd1ee39e5 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        In some studies involving longer periods of plasma sampling, a longer terminal half-life of morphine sulfate of about 15 hours was reported.

    2. 2 to 4 hours

      Numeric value
      2
      Unit
      hours
      Source records
      24

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 24 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad08cd86-3825-4e77-bbe8-f6333a9ca9d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f15f27b-95ed-4cc8-8937-eae07917a6dd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a89d0ca-4ff8-4bdc-8ea8-9ad591ce7226 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20af0f0e-45cc-4795-97ef-90b659575b34 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:533034fd-c8e7-495b-8874-0db41bd1e65a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dbb37dfd-0196-45f7-b9ca-393f56cf1d28 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:872ceecb-1f14-7a43-7451-e4650a01fbd9 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73a39ce5-b2ab-47b9-8860-796f1d5bc8d8 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c94d9da6-7a12-44ee-a38f-3323ee27842c (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c354b3bf-86c0-4bb8-8b1f-be2164942698 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a1ca529-8268-4be3-b03f-b2f2238cc9dc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7f65fa22-c3fc-4413-8a07-2c6be621b7bf (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f915420d-981d-455b-b4cf-67c8e201a136 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07993f6c-146b-4728-a2da-6e93089f78ff (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:736c9b80-682c-4cda-bf18-61b18de0bd39 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb9f929b-8c5a-442b-9695-9d3d45272a5e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd98b881-5466-457b-b5af-f102aec61546 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:47ea2424-ce2f-4b3b-b393-da1886e7a383 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc3b491c-a206-3027-54f0-f87c0dd40a7f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2dd52157-3121-41ed-abc2-99b269531e56 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19c7d9cc-6ce2-4c5c-8c3f-c24fd3342804 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e310662-16e8-4179-883e-efbca736b14d (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d360a33f-6323-4b10-9e81-07e2813c2dbd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:595243fe-a4b1-479a-99d6-a084a4181891 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Excretion The elimination of morphine occurs primarily as renal excretion of M3G and its effective half-life after intravenous administration is normally 2 to 4 hours.

    3. 1.5 to 4.5 hours

      Numeric value
      1.5
      Unit
      hours
      Source records
      10

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 10 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be420e8b-bcb0-49b5-bb4d-1df8b9959809 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9362eca1-2bc9-4f72-8895-0b9179bfeb2b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6023606c-150c-40c5-9175-598efe2a56c3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1034467f-d436-4b87-a902-c7e8885daa8a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ebb18761-e5c4-4238-bb84-f9549f500210 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half‑lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:582f42e5-444e-4246-af8c-e7e28097c69a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:69a0d5be-3211-4b7f-962b-e9d9a507321f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee8057d1-ed12-4e18-9efa-d83504abf612 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f53de80-efc8-4930-b3e3-fba0d026af05 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d181906-f3ec-4222-1883-e61577a3122e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Terminal half-life is commonly reported to vary from 1.5 to 4.5 hours, although the longer half-lives were obtained when morphine levels were monitored over protracted periods with very sensitive radioimmunoassay methods.

    4. 2 hours

      Numeric value
      2
      Unit
      hours
      Source records
      4

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 4 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2da87bfa-11fd-43e3-8fef-d16ebeb15680 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The effective terminal half-life of morphine after IV administration is reported to be approximately 2 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7e9a4b3-a2ee-4f0a-becd-6ef90867332b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The effective terminal half-life of morphine after IV administration is reported to be approximately 2 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97948a8f-7d1b-4614-b11d-e944cf56590b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The effective terminal half-life of morphine after IV administration is reported to be approximately 2 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c1a5b8b-8faa-4ee0-80bd-853c239bb1c4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The effective terminal half-life of morphine after IV administration is reported to be approximately 2 hours.

  9. Projected row 1039

    Medicine slug
    morphine
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    75
    Source count
    10
    Agreement rate
    1
    Recorded readings

    1. 36%

      Numeric value
      36
      Unit
      %
      Source records
      10

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 10 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be420e8b-bcb0-49b5-bb4d-1df8b9959809 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9362eca1-2bc9-4f72-8895-0b9179bfeb2b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6023606c-150c-40c5-9175-598efe2a56c3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1034467f-d436-4b87-a902-c7e8885daa8a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ebb18761-e5c4-4238-bb84-f9549f500210 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:582f42e5-444e-4246-af8c-e7e28097c69a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:69a0d5be-3211-4b7f-962b-e9d9a507321f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee8057d1-ed12-4e18-9efa-d83504abf612 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f53de80-efc8-4930-b3e3-fba0d026af05 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d181906-f3ec-4222-1883-e61577a3122e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Protein binding is low, about 36%, and muscle tissue binding is reported as 54%.

  10. Projected row 1040

    Medicine slug
    morphine
    Compared field
    volumeOfDistribution
    Comparison state
    not_comparable
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    • DENOMINATOR_MISMATCH
    Documents examined
    75
    Source count
    71
    Agreement rate
    0.478873
    Recorded readings

    1. 1 to 6 L/kg

      Numeric value
      1
      Unit
      L/kg
      Source records
      34

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 34 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2da87bfa-11fd-43e3-8fef-d16ebeb15680 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine is approximately 1 to 6 L/kg, and morphine is 20 to 35% reversibly bound to plasma proteins.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4f9a7cd-fa6c-41cd-8c4b-04626cfa410a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20 to 35% reversibly bound to plasma proteins.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:efccad6e-213b-4335-9a4f-3b81322f77c4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20 to 35% reversibly bound to plasma proteins.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:300b6afd-bac8-32ca-e063-6294a90a12a7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5ceb3205-2f8d-4ba3-9f27-dc328bab4fa1 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b7b86b6d-9a39-494c-bf65-f62e4cdc5807 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae57637e-a86a-4ea5-9c68-47d98153d41a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:996ac31e-589f-4d5a-84bc-8350e7ea864f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20 to 35% reversibly bound to plasma proteins.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8d800d8e-8fe2-453b-a8ac-dcf7c47e55fc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6654b91e-3b3f-4062-ac65-a2a70f942da4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5422cdac-8073-41fc-8665-ffe9797f5c02 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e9a7319a-bf1f-48db-a71e-6d4e6ead9555 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:905cd842-2c86-4318-a6c4-92f49de145b3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d66d0cfb-9bfe-490c-90ee-49481c567e85 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca359246-4674-4b32-b8b2-673d32b7112f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d8598654-94ad-4cfb-81d2-9b68e013a428 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b69f67f-30b3-4982-953e-5a4b87ec6ac6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58476a6b-b54b-5491-e063-6394a90a38c6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:72e2071a-43d6-4480-bb84-4984a976618b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20 to 35% reversibly bound to plasma proteins.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:367d508b-3226-42a9-8dc6-f67cdc9979f3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3c847554-3b4b-4d24-a145-2ef7e9b83699 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9405556c-20e0-4e47-b1b0-7872bcc6517e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57ee014e-744e-65e1-e063-6394a90a8c93 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb6b3439-9f0c-45f5-bf6f-c7a971af0a8f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e32b869-31c7-48c1-98ae-b21bd28151d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9bb1fef7-4159-4dca-8a8c-37e53ccc6bab (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f1ba2a2-d8ac-4f59-a587-fe413e56dcdb (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b0b4ac-69d9-44bf-b7a3-229bd89b9fd6 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:242c2512-1d49-486b-a9c3-6905f667799e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:649d731b-962a-45df-b043-7e0781e8a530 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20 to 35% reversibly bound to plasma proteins.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67f0ee8d-696e-4c08-9007-3df0e3988bad (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76966c05-df75-4072-ae99-97e42f91ab75 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07593aa4-f2c4-4d6e-b186-ab2a4ecaa38a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:66a3f607-7f48-490f-84dd-b74dd1ee39e5 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine sulfate is approximately 1 to 6 L/kg, and morphine sulfate is 20% to 35% reversibly bound to plasma proteins.

    2. 3 to 4 liters

      Numeric value
      3
      Unit
      L
      Source records
      24

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 24 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ad08cd86-3825-4e77-bbe8-f6333a9ca9d7 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f15f27b-95ed-4cc8-8937-eae07917a6dd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a89d0ca-4ff8-4bdc-8ea8-9ad591ce7226 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20af0f0e-45cc-4795-97ef-90b659575b34 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:533034fd-c8e7-495b-8874-0db41bd1e65a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dbb37dfd-0196-45f7-b9ca-393f56cf1d28 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:872ceecb-1f14-7a43-7451-e4650a01fbd9 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73a39ce5-b2ab-47b9-8860-796f1d5bc8d8 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c94d9da6-7a12-44ee-a38f-3323ee27842c (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c354b3bf-86c0-4bb8-8b1f-be2164942698 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a1ca529-8268-4be3-b03f-b2f2238cc9dc (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7f65fa22-c3fc-4413-8a07-2c6be621b7bf (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f915420d-981d-455b-b4cf-67c8e201a136 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07993f6c-146b-4728-a2da-6e93089f78ff (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:736c9b80-682c-4cda-bf18-61b18de0bd39 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb9f929b-8c5a-442b-9695-9d3d45272a5e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd98b881-5466-457b-b5af-f102aec61546 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:47ea2424-ce2f-4b3b-b393-da1886e7a383 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cc3b491c-a206-3027-54f0-f87c0dd40a7f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2dd52157-3121-41ed-abc2-99b269531e56 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19c7d9cc-6ce2-4c5c-8c3f-c24fd3342804 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e310662-16e8-4179-883e-efbca736b14d (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d360a33f-6323-4b10-9e81-07e2813c2dbd (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:595243fe-a4b1-479a-99d6-a084a4181891 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution (Vd) for morphine is approximately 3 to 4 liters per kilogram and morphine is 30 to 35% reversibly bound to plasma proteins.

    3. 1.0 to 4.7 L/kg

      Numeric value
      1
      Unit
      L/kg
      Source records
      9

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 9 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be420e8b-bcb0-49b5-bb4d-1df8b9959809 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Distribution Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after parenteral administration.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9362eca1-2bc9-4f72-8895-0b9179bfeb2b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Distribution Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after parenteral administration.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6023606c-150c-40c5-9175-598efe2a56c3 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Distribution Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after parenteral administration.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ebb18761-e5c4-4238-bb84-f9549f500210 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Intravenous Administration Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after intravenous dosage.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:582f42e5-444e-4246-af8c-e7e28097c69a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Distribution : Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after intravenous dosage .
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:69a0d5be-3211-4b7f-962b-e9d9a507321f (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Distribution Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after parenteral administration.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ee8057d1-ed12-4e18-9efa-d83504abf612 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Distribution Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after parenteral administration.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1f53de80-efc8-4930-b3e3-fba0d026af05 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Distribution: Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after intravenous dosage .
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d181906-f3ec-4222-1883-e61577a3122e (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Intravenous Administration Morphine has an apparent volume of distribution ranging from 1.0 to 4.7 L/kg after intravenous dosage.

    4. 3 to 4 L/kg

      Numeric value
      3
      Unit
      L/kg
      Source records
      2

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 2 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7e9a4b3-a2ee-4f0a-becd-6ef90867332b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine is approximately 3 to 4 L/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c1a5b8b-8faa-4ee0-80bd-853c239bb1c4 (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine is approximately 3 to 4 L/kg.

    5. 1 to 4.7 L/kg

      Numeric value
      1
      Unit
      L/kg
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1034467f-d436-4b87-a902-c7e8885daa8a (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        Distribution Morphine has an apparent volume of distribution ranging from 1 to 4.7 L/kg after intravenous dosage.

    6. 3 L/kg

      Numeric value
      3
      Unit
      L/kg
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:97948a8f-7d1b-4614-b11d-e944cf56590b (opens source in a new tab)

        Morphine label

        Version not recorded · Effective date not recorded

        The volume of distribution of morphine is approximately 3 L/kg to 4 L/kg.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=1030

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy